Cargando…

Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer

Drug repositioning is a popular approach in the pharmaceutical industry for identifying potential new uses for existing drugs and accelerating the development time. Non-small-cell lung cancer (NSCLC) is one of the leading causes of death worldwide. To reduce the biological heterogeneity effects amon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chien-Hung, Chang, Peter Mu-Hsin, Lin, Yong-Jie, Wang, Cheng-Hsu, Huang, Chi-Ying F., Ng, Ka-Lok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156989/ https://www.ncbi.nlm.nih.gov/pubmed/25210704 http://dx.doi.org/10.1155/2014/193817

Ejemplares similares

Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory
por: Huang, Chien-Hung, et al.
Publicado: (2016)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Repositioning Natural Products in Drug Discovery
por: Rastelli, Giulio, et al.
Publicado: (2020)

Large-scale Direct Targeting for Drug Repositioning and Discovery
por: Zheng, Chunli, et al.
Publicado: (2015)

DrugCentral 2021 supports drug discovery and repositioning
por: Avram, Sorin, et al.
Publicado: (2020)

Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
por: Shim, Joong Sup, et al.
Publicado: (2014)

Drug repositioning: Progress and challenges in drug discovery for various diseases
por: Hua, Yi, et al.
Publicado: (2022)

Drug repositioning can accelerate discovery of pharmacological chaperones
por: Hay Mele, Bruno, et al.
Publicado: (2015)

Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer
por: Al-Taie, Zainab, et al.
Publicado: (2021)

Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
por: Langhans, Sigrid A.
Publicado: (2018)

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
por: Zhang, Cheng, et al.
Publicado: (2022)

Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning
por: Wong, Henry Sung-Ching, et al.
Publicado: (2019)

Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction
por: Coelho, Edgar D., et al.
Publicado: (2016)

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 Treatment
por: Tsai, Ming-Ju, et al.
Publicado: (2023)

A review on computer‐aided chemogenomics and drug repositioning for rational COVID‐19 drug discovery
por: Maghsoudi, Saeid, et al.
Publicado: (2022)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Review of Drug Repositioning Approaches and Resources
por: Xue, Hanqing, et al.
Publicado: (2018)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning
por: Riva, Laura, et al.
Publicado: (2020)

MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer
por: Ye, Qing, et al.
Publicado: (2023)

Drug repositioning in sarcomas and other rare tumors
por: Lee, Alex T.J., et al.
Publicado: (2016)

Prediction of Cancer Proteins by Integrating Protein Interaction, Domain Frequency, and Domain Interaction Data Using Machine Learning Algorithms
por: Huang, Chien-Hung, et al.
Publicado: (2015)

Drug repositioning for esophageal squamous cell carcinoma
por: Bennett, Adam N., et al.
Publicado: (2022)

Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces
por: Zheng, Yi, et al.
Publicado: (2019)

Using Functional Signatures to Identify Repositioned Drugs for Breast, Myelogenous Leukemia and Prostate Cancer
por: Shigemizu, Daichi, et al.
Publicado: (2012)

Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
por: Turanli, Beste, et al.
Publicado: (2019)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

GREP: genome for REPositioning drugs
por: Sakaue, Saori, et al.
Publicado: (2019)

Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Pluripotency‐associated genes reposition during early embryonic developmental stages in pigs
por: Nguyen, Hiep Thi, et al.
Publicado: (2020)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
por: Parisi, Daniele, et al.
Publicado: (2020)

DrugSig: A resource for computational drug repositioning utilizing gene expression signatures
por: Wu, Hongyu, et al.
Publicado: (2017)

Concept Modeling-based Drug Repositioning
por: Patchala, Jagadeesh, et al.
Publicado: (2015)

Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)

Changing Trends in Computational Drug Repositioning
por: Yella, Jaswanth K., et al.
Publicado: (2018)

The Immunogenetics of Psoriasis and Implications for Drug Repositioning
por: Xu, Xuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qvg4kfmk3ih0tg9rqj4ovnnslv